O16-5 Epcoritamab in Japanese patients with relapsed/refractory diffuse large B-cell lymphoma: EPCORE NHL-3 longer-term data
Year: 2024
Type: article
Source: Annals of Oncology
Authors: K. Izutsu, T. Kumode, J. Yuda, H. Nagai, Y. Mishima, Y. Suehiro, K. Yamamoto, T. Fujisaki, K. Ishitsuka, K. Ishizawa, T. Ikezoe, M. Nishikori, D. Akahane, J. Fujita, P. Jafarinasabian, H. Noguchi, J. Buchbjerg, E. Favaro, N. Fukuhara
Institutions: National Cancer Center Hospital, Kindai University, National Cancer Center Hospital East, Nagoya Medical Center, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, National Hospital Organization Kyushu Cancer Center, Aichi Cancer Center, Matsuyama Red Cross Hospital, Kagoshima University, Yamagata University, Fukushima Medical University Hospital, Kyoto University, Tokyo Medical University, The University of Osaka, AbbVie (United States), Genmab (Denmark), Tohoku University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Eisai, Chugai Pharmaceutical
OpenAlex ID: W4403797906